OAM
DERM

Oxford Asset Management’s Dermira, Inc. DERM Stock Holding History

Oxford Asset Management’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-17,841
Closed -$170K – 2059
2018
Q2 		$170K Buy
+17,841
New +$166K ﹤0.01% 1604

Other funds holding DERM

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Oxford Asset Management's DERM Position: Q3 2018 in Review

Oxford Asset Management sold out of Dermira, Inc. (DERM) in Q3 2018, closing a stake of 17,841 shares — an estimated $170K sold.

Oxford Asset Management first reported a position in DERM in Q2 2018 and held it in 1 quarter. The position peaked at $170K in Q2 2018. 105 funds tracked by Wall St. Rank hold DERM as of Q3 2018.

  • Oxford Asset Management reported no remaining Dermira, Inc. position as of Q3 2018 after selling out during the quarter.
  • Oxford Asset Management sold 17,841 Dermira, Inc. shares in Q3 2018, an estimated $170K.
  • Oxford Asset Management first reported a position in Dermira, Inc. in Q2 2018 and held it in 1 quarter.
  • Oxford Asset Management's Dermira, Inc. position peaked at $170K in Q2 2018.
  • 105 funds tracked by Wall St. Rank held Dermira, Inc. as of Q3 2018.

Based on Oxford Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.